1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 External
        1.2.3 Internal
        1.2.4 Composite
        1.2.5 Injection
    1.3 Market by Application
        1.3.1 Global Pet Anthelmintic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Dog
        1.3.3 Cat
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pet Anthelmintic Drugs Market Perspective (2017-2028)
    2.2 Pet Anthelmintic Drugs Growth Trends by Region
        2.2.1 Pet Anthelmintic Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pet Anthelmintic Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Pet Anthelmintic Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Pet Anthelmintic Drugs Market Dynamics
        2.3.1 Pet Anthelmintic Drugs Industry Trends
        2.3.2 Pet Anthelmintic Drugs Market Drivers
        2.3.3 Pet Anthelmintic Drugs Market Challenges
        2.3.4 Pet Anthelmintic Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pet Anthelmintic Drugs Players by Revenue
        3.1.1 Global Top Pet Anthelmintic Drugs Players by Revenue (2017-2022)
        3.1.2 Global Pet Anthelmintic Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Pet Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pet Anthelmintic Drugs Revenue
    3.4 Global Pet Anthelmintic Drugs Market Concentration Ratio
        3.4.1 Global Pet Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pet Anthelmintic Drugs Revenue in 2021
    3.5 Pet Anthelmintic Drugs Key Players Head office and Area Served
    3.6 Key Players Pet Anthelmintic Drugs Product Solution and Service
    3.7 Date of Enter into Pet Anthelmintic Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Anthelmintic Drugs Breakdown Data by Type
    4.1 Global Pet Anthelmintic Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2023-2028)
5 Pet Anthelmintic Drugs Breakdown Data by Application
    5.1 Global Pet Anthelmintic Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pet Anthelmintic Drugs Market Size (2017-2028)
    6.2 North America Pet Anthelmintic Drugs Market Size by Type
        6.2.1 North America Pet Anthelmintic Drugs Market Size by Type (2017-2022)
        6.2.2 North America Pet Anthelmintic Drugs Market Size by Type (2023-2028)
        6.2.3 North America Pet Anthelmintic Drugs Market Share by Type (2017-2028)
    6.3 North America Pet Anthelmintic Drugs Market Size by Application
        6.3.1 North America Pet Anthelmintic Drugs Market Size by Application (2017-2022)
        6.3.2 North America Pet Anthelmintic Drugs Market Size by Application (2023-2028)
        6.3.3 North America Pet Anthelmintic Drugs Market Share by Application (2017-2028)
    6.4 North America Pet Anthelmintic Drugs Market Size by Country
        6.4.1 North America Pet Anthelmintic Drugs Market Size by Country (2017-2022)
        6.4.2 North America Pet Anthelmintic Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Pet Anthelmintic Drugs Market Size (2017-2028)
    7.2 Europe Pet Anthelmintic Drugs Market Size by Type
        7.2.1 Europe Pet Anthelmintic Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Pet Anthelmintic Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Pet Anthelmintic Drugs Market Share by Type (2017-2028)
    7.3 Europe Pet Anthelmintic Drugs Market Size by Application
        7.3.1 Europe Pet Anthelmintic Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Pet Anthelmintic Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Pet Anthelmintic Drugs Market Share by Application (2017-2028)
    7.4 Europe Pet Anthelmintic Drugs Market Size by Country
        7.4.1 Europe Pet Anthelmintic Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Pet Anthelmintic Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pet Anthelmintic Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type
        8.2.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Pet Anthelmintic Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application
        8.3.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Pet Anthelmintic Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region
        8.4.1 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Pet Anthelmintic Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Pet Anthelmintic Drugs Market Size (2017-2028)
    9.2 Latin America Pet Anthelmintic Drugs Market Size by Type
        9.2.1 Latin America Pet Anthelmintic Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Pet Anthelmintic Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Pet Anthelmintic Drugs Market Share by Type (2017-2028)
    9.3 Latin America Pet Anthelmintic Drugs Market Size by Application
        9.3.1 Latin America Pet Anthelmintic Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Pet Anthelmintic Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Pet Anthelmintic Drugs Market Share by Application (2017-2028)
    9.4 Latin America Pet Anthelmintic Drugs Market Size by Country
        9.4.1 Latin America Pet Anthelmintic Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Pet Anthelmintic Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pet Anthelmintic Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type
        10.2.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Pet Anthelmintic Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application
        10.3.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Pet Anthelmintic Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country
        10.4.1 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Pet Anthelmintic Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Elanco
        11.1.1 Elanco Company Details
        11.1.2 Elanco Business Overview
        11.1.3 Elanco Pet Anthelmintic Drugs Introduction
        11.1.4 Elanco Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.1.5 Elanco Recent Developments
    11.2 Boehringer Ingelheim
        11.2.1 Boehringer Ingelheim Company Details
        11.2.2 Boehringer Ingelheim Business Overview
        11.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Introduction
        11.2.4 Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.2.5 Boehringer Ingelheim Recent Developments
    11.3 Ceva Sante Animale
        11.3.1 Ceva Sante Animale Company Details
        11.3.2 Ceva Sante Animale Business Overview
        11.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Introduction
        11.3.4 Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.3.5 Ceva Sante Animale Recent Developments
    11.4 Chanelle Group
        11.4.1 Chanelle Group Company Details
        11.4.2 Chanelle Group Business Overview
        11.4.3 Chanelle Group Pet Anthelmintic Drugs Introduction
        11.4.4 Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.4.5 Chanelle Group Recent Developments
    11.5 Dechra
        11.5.1 Dechra Company Details
        11.5.2 Dechra Business Overview
        11.5.3 Dechra Pet Anthelmintic Drugs Introduction
        11.5.4 Dechra Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.5.5 Dechra Recent Developments
    11.6 Durvet
        11.6.1 Durvet Company Details
        11.6.2 Durvet Business Overview
        11.6.3 Durvet Pet Anthelmintic Drugs Introduction
        11.6.4 Durvet Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.6.5 Durvet Recent Developments
    11.7 First Priority
        11.7.1 First Priority Company Details
        11.7.2 First Priority Business Overview
        11.7.3 First Priority Pet Anthelmintic Drugs Introduction
        11.7.4 First Priority Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.7.5 First Priority Recent Developments
    11.8 Jeffers
        11.8.1 Jeffers Company Details
        11.8.2 Jeffers Business Overview
        11.8.3 Jeffers Pet Anthelmintic Drugs Introduction
        11.8.4 Jeffers Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.8.5 Jeffers Recent Developments
    11.9 Manna Pro Products
        11.9.1 Manna Pro Products Company Details
        11.9.2 Manna Pro Products Business Overview
        11.9.3 Manna Pro Products Pet Anthelmintic Drugs Introduction
        11.9.4 Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.9.5 Manna Pro Products Recent Developments
    11.10 Merck Animal Health
        11.10.1 Merck Animal Health Company Details
        11.10.2 Merck Animal Health Business Overview
        11.10.3 Merck Animal Health Pet Anthelmintic Drugs Introduction
        11.10.4 Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.10.5 Merck Animal Health Recent Developments
    11.11 Ourofino
        11.11.1 Ourofino Company Details
        11.11.2 Ourofino Business Overview
        11.11.3 Ourofino Pet Anthelmintic Drugs Introduction
        11.11.4 Ourofino Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.11.5 Ourofino Recent Developments
    11.12 TTK Healthcare
        11.12.1 TTK Healthcare Company Details
        11.12.2 TTK Healthcare Business Overview
        11.12.3 TTK Healthcare Pet Anthelmintic Drugs Introduction
        11.12.4 TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.12.5 TTK Healthcare Recent Developments
    11.13 Vetoquinol
        11.13.1 Vetoquinol Company Details
        11.13.2 Vetoquinol Business Overview
        11.13.3 Vetoquinol Pet Anthelmintic Drugs Introduction
        11.13.4 Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.13.5 Vetoquinol Recent Developments
    11.14 Virbac
        11.14.1 Virbac Company Details
        11.14.2 Virbac Business Overview
        11.14.3 Virbac Pet Anthelmintic Drugs Introduction
        11.14.4 Virbac Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.14.5 Virbac Recent Developments
    11.15 Zoetis
        11.15.1 Zoetis Company Details
        11.15.2 Zoetis Business Overview
        11.15.3 Zoetis Pet Anthelmintic Drugs Introduction
        11.15.4 Zoetis Revenue in Pet Anthelmintic Drugs Business (2017-2022)
        11.15.5 Zoetis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Pet Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of External
    Table 3. Key Players of Internal
    Table 4. Key Players of Composite
    Table 5. Key Players of Injection
    Table 6. Global Pet Anthelmintic Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Pet Anthelmintic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Pet Anthelmintic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Pet Anthelmintic Drugs Market Share by Region (2017-2022)
    Table 10. Global Pet Anthelmintic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Pet Anthelmintic Drugs Market Share by Region (2023-2028)
    Table 12. Pet Anthelmintic Drugs Market Trends
    Table 13. Pet Anthelmintic Drugs Market Drivers
    Table 14. Pet Anthelmintic Drugs Market Challenges
    Table 15. Pet Anthelmintic Drugs Market Restraints
    Table 16. Global Pet Anthelmintic Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Pet Anthelmintic Drugs Revenue Share by Players (2017-2022)
    Table 18. Global Top Pet Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2021)
    Table 19. Ranking of Global Top Pet Anthelmintic Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Pet Anthelmintic Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Pet Anthelmintic Drugs Product Solution and Service
    Table 23. Date of Enter into Pet Anthelmintic Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Pet Anthelmintic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Pet Anthelmintic Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Pet Anthelmintic Drugs Revenue Share by Application (2017-2022)
    Table 31. Global Pet Anthelmintic Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Pet Anthelmintic Drugs Revenue Share by Application (2023-2028)
    Table 33. North America Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Pet Anthelmintic Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Pet Anthelmintic Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Pet Anthelmintic Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Pet Anthelmintic Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Pet Anthelmintic Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Pet Anthelmintic Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Pet Anthelmintic Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Pet Anthelmintic Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Elanco Company Details
    Table 64. Elanco Business Overview
    Table 65. Elanco Pet Anthelmintic Drugs Product
    Table 66. Elanco Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 67. Elanco Recent Developments
    Table 68. Boehringer Ingelheim Company Details
    Table 69. Boehringer Ingelheim Business Overview
    Table 70. Boehringer Ingelheim Pet Anthelmintic Drugs Product
    Table 71. Boehringer Ingelheim Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 72. Boehringer Ingelheim Recent Developments
    Table 73. Ceva Sante Animale Company Details
    Table 74. Ceva Sante Animale Business Overview
    Table 75. Ceva Sante Animale Pet Anthelmintic Drugs Product
    Table 76. Ceva Sante Animale Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 77. Ceva Sante Animale Recent Developments
    Table 78. Chanelle Group Company Details
    Table 79. Chanelle Group Business Overview
    Table 80. Chanelle Group Pet Anthelmintic Drugs Product
    Table 81. Chanelle Group Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 82. Chanelle Group Recent Developments
    Table 83. Dechra Company Details
    Table 84. Dechra Business Overview
    Table 85. Dechra Pet Anthelmintic Drugs Product
    Table 86. Dechra Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 87. Dechra Recent Developments
    Table 88. Durvet Company Details
    Table 89. Durvet Business Overview
    Table 90. Durvet Pet Anthelmintic Drugs Product
    Table 91. Durvet Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 92. Durvet Recent Developments
    Table 93. First Priority Company Details
    Table 94. First Priority Business Overview
    Table 95. First Priority Pet Anthelmintic Drugs Product
    Table 96. First Priority Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 97. First Priority Recent Developments
    Table 98. Jeffers Company Details
    Table 99. Jeffers Business Overview
    Table 100. Jeffers Pet Anthelmintic Drugs Product
    Table 101. Jeffers Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 102. Jeffers Recent Developments
    Table 103. Manna Pro Products Company Details
    Table 104. Manna Pro Products Business Overview
    Table 105. Manna Pro Products Pet Anthelmintic Drugs Product
    Table 106. Manna Pro Products Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 107. Manna Pro Products Recent Developments
    Table 108. Merck Animal Health Company Details
    Table 109. Merck Animal Health Business Overview
    Table 110. Merck Animal Health Pet Anthelmintic Drugs Product
    Table 111. Merck Animal Health Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 112. Merck Animal Health Recent Developments
    Table 113. Ourofino Company Details
    Table 114. Ourofino Business Overview
    Table 115. Ourofino Pet Anthelmintic Drugs Product
    Table 116. Ourofino Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 117. Ourofino Recent Developments
    Table 118. TTK Healthcare Company Details
    Table 119. TTK Healthcare Business Overview
    Table 120. TTK Healthcare Pet Anthelmintic Drugs Product
    Table 121. TTK Healthcare Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 122. TTK Healthcare Recent Developments
    Table 123. Vetoquinol Company Details
    Table 124. Vetoquinol Business Overview
    Table 125. Vetoquinol Pet Anthelmintic Drugs Product
    Table 126. Vetoquinol Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 127. Vetoquinol Recent Developments
    Table 128. Virbac Company Details
    Table 129. Virbac Business Overview
    Table 130. Virbac Pet Anthelmintic Drugs Product
    Table 131. Virbac Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 132. Virbac Recent Developments
    Table 133. Zoetis Company Details
    Table 134. Zoetis Business Overview
    Table 135. Zoetis Pet Anthelmintic Drugs Product
    Table 136. Zoetis Revenue in Pet Anthelmintic Drugs Business (2017-2022) & (US$ Million)
    Table 137. Zoetis Recent Developments
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pet Anthelmintic Drugs Market Share by Type: 2021 VS 2028
    Figure 2. External Features
    Figure 3. Internal Features
    Figure 4. Composite Features
    Figure 5. Injection Features
    Figure 6. Global Pet Anthelmintic Drugs Market Share by Application: 2021 VS 2028
    Figure 7. Dog Case Studies
    Figure 8. Cat Case Studies
    Figure 9. Others Case Studies
    Figure 10. Pet Anthelmintic Drugs Report Years Considered
    Figure 11. Global Pet Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Pet Anthelmintic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Pet Anthelmintic Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Pet Anthelmintic Drugs Market Share by Players in 2021
    Figure 15. Global Top Pet Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Anthelmintic Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2021
    Figure 17. North America Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 19. North America Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 20. North America Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 21. United States Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 27. Germany Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Pet Anthelmintic Drugs Market Size Share by Region (2017-2028)
    Figure 37. China Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 47. Mexico Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Pet Anthelmintic Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Pet Anthelmintic Drugs Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Pet Anthelmintic Drugs Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Pet Anthelmintic Drugs Market Size Share by Country (2017-2028)
    Figure 53. Turkey Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Pet Anthelmintic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Elanco Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 57. Boehringer Ingelheim Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 58. Ceva Sante Animale Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 59. Chanelle Group Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 60. Dechra Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 61. Durvet Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 62. First Priority Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 63. Jeffers Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 64. Manna Pro Products Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 65. Merck Animal Health Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 66. Ourofino Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 67. TTK Healthcare Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 68. Vetoquinol Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 69. Virbac Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 70. Zoetis Revenue Growth Rate in Pet Anthelmintic Drugs Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed